Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
7.67M
-
Shares change
-
-306K
-
Total reported value, excl. options
-
$68.2M
-
Value change
-
-$2.74M
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$8.87
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q3 2021
21 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q3 2021.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.67M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (2.29M shares), Cormorant Asset Management, LP (2.27M shares), FMR LLC (1.69M shares), FARALLON CAPITAL MANAGEMENT LLC (811K shares), VANGUARD GROUP INC (173K shares), ORBIMED ADVISORS LLC (114K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (70K shares), Alyeska Investment Group, L.P. (62.5K shares), TD ASSET MANAGEMENT INC (57.3K shares), and Integral Health Asset Management, LLC (30K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.